This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $229,500
The Emerging Field of Cardiovascular-Oncology: Role of Tumor Suppressor Breast Cancer Susceptibility Gene 2 (BRCA2) in Endothelial Dysfunction and Atherosclerosis
CIHR · 2016 · Nominated PI
- $765,000
BRCA1 therapy for heart failure
CIHR · 2016 · Principal investigator
The Emerging Field of Cardiovascular-Oncology: Role of Tumor Suppressor Breast Cancer Susceptibility Gene 2 (BRCA2) in Endothelial Dysfunction and Atherosclerosis
Principal investigators: Singh, Krishna K
Keywords: Brca2; Breast Cancer; Dna Damage & Repair; Endothelial Biology; Tissue-Specific Knockout Mouse Generation
BRCA1 therapy for heart failure
Principal investigators: Verma, Subodh S; Fedak, Paul William M; Singh, Krishna K
Keywords: Brca1; Gene Delivery (Aav9-Brca1); Heart Failure; Murine Genotoxic Stress Model; Murine Hypertrophy Model,; Murine Myocardial Infarction Model; Porcine Myocardial Infarction Model
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.